A pilot study utilizing - Side
A Physicist Looks at Cancer
A Phenomenological Examination: African American Women and
A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients
A Phase III, Randomized, Double-Blind, Placebo
A phase III randomized trial of niraparib versus physician`s
A Phase III Randomized Trial Comparing Patient Reported Toxicity
A phase IIa, nonrandomized study of radium
A Phase II/III Trial of Weekly nab-Paclitaxel Plus Gemcitabine or
A Phase II/III Randomized Trial of Two Doses of MK-3475
A phase II, randomized multi-center study of MDX
A Phase II Trial of Perifosine in Patients with Chemo
A phase II study of weekly irinotecan in patients with locally
A Phase II Study of the PARP Inhibitor, Iniparib (BSI-201), in Combination with Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
A Phase II Study of Temozolomide in Patients with Advanced
A phase II study of paclitaxel in advanced
A phase II study of gemcitabine in gallbladder carcinoma
A phase II study of Epirubicin in oxaliplatin
a phase ii randomized trial with captopril in patients who have
A Phase I, open-label, dose-escalation study of continuous once
A phase I, first in human study of FP-1039
